Literature DB >> 7556337

Neurological deterioration in patients with urea cycle disorders under valproate therapy--a cause for concern.

A C Sewell, H J Böhles, J Herwig, M Demirkol.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556337     DOI: 10.1007/bf02074851

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

1.  Valproate-induced lethal hyperammonaemic coma in a carrier of ornithine carbamoyltransferase deficiency.

Authors:  A Tokatli; T Coşkun; S Cataltepe; I Ozalp
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Arginase deficiency presenting with convulsions.

Authors:  J S Patel; W V van't Hoff; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Hyperammonemia with valproic acid therapy.

Authors:  D L Coulter; R J Allen
Journal:  J Pediatr       Date:  1981-08       Impact factor: 4.406

4.  Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy.

Authors:  D Honeycutt; K Callahan; L Rutledge; B Evans
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

Review 5.  [Late diagnosis of congenital argininemia during administration of sodium valproate].

Authors:  D Christmann; E Hirsch; V Mutschler; M Collard; C Marescaux; J P Colombo
Journal:  Rev Neurol (Paris)       Date:  1990       Impact factor: 2.607

  5 in total
  3 in total

Review 1.  Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.

Authors:  M F B Silva; C C P Aires; P B M Luis; J P N Ruiter; L IJlst; M Duran; R J A Wanders; I Tavares de Almeida
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

2.  Regulation of metabolic networks by small molecule metabolites.

Authors:  Alex Gutteridge; Minoru Kanehisa; Susumu Goto
Journal:  BMC Bioinformatics       Date:  2007-03-13       Impact factor: 3.169

3.  Severe valproate induced hyperammonemic encephalopathy successfully managed with peritoneal dialysis.

Authors:  Amandeep Kumar; Ashish Suri; Bhawani S Sharma
Journal:  Indian J Crit Care Med       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.